1-3 of 3
Auro Viswabandya
Close
Sort by
Journal Articles

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era

Anand A. Patel, James J. Yoon, Hannah Johnston, Marta B. Davidson, Rory M. Shallis, Evan C. Chen, Madelyn Burkart, Timothy S. Oh, Sunil G. Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K. Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin Abaza, Jacqueline S. Garcia, Vikas Gupta, Kristen M. Pettit, John F. Cursio, Olatoyosi Odenike
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3468–3477.
https://doi.org/10.1182/bloodadvances.2024012880
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN

Marta B. Davidson, James A. Kennedy, Jose-Mario Capo-Chichi, Yuliang Shi, Wei Xu, Verna Cheung, Andrea Arruda, Aniket Bankar, Guillaume Richard-Carpentier, Steven Chan, Dawn Maze, Mark D. Minden, Aaron D. Schimmer, Andre C. Schuh, Hassan Sibai, Karen Yee, Anne Tierens, Auro Viswabandya, Vikas Gupta
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1281–1294.
https://doi.org/10.1182/bloodadvances.2023011735
Published: 2024
Includes: Supplemental data
Journal Articles

The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes

Clinical Trials & Observations
Caroline J. McNamara, Tony Panzarella, James A. Kennedy, Andrea Arruda, Jaime O. Claudio, Georgina Daher-Reyes, Jenny Ho, Nancy Siddiq, Rebecca Devlin, Hubert Tsui, Jie Su, Tracy Stockley, Mahadeo Sukhai, Nisha Kanwar, Steven Chan, Dawn Maze, Aaron Schimmer, Andre Schuh, Hassan Sibai, Auro Viswabandya, Karen Yee, Mark D. Minden, Suzanne Kamel-Reid, Vikas Gupta
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2658–2671.
https://doi.org/10.1182/bloodadvances.2018021469
Published: 2018
Includes: Supplemental data